Cited 24 times in
Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 조상래 | - |
dc.date.accessioned | 2017-10-26T07:27:58Z | - |
dc.date.available | 2017-10-26T07:27:58Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 0066-4804 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/152068 | - |
dc.description.abstract | Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment. | - |
dc.description.statementOfResponsibility | open | - |
dc.publisher | American Society for Microbiology | - |
dc.relation.isPartOf | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Antitubercular Agents/pharmacology* Bacterial Proteins/genetics Drug Resistance, Bacterial/genetics Ethambutol/pharmacology* Microbial Sensitivity Tests Mutation/genetics* Mycobacterium tuberculosis/drug effects* Mycobacterium tuberculosis/genetics* | - |
dc.title | Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis | - |
dc.type | Article | - |
dc.publisher.location | United States | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Microbiology | - |
dc.contributor.googleauthor | Subramanya Lingaraju | - |
dc.contributor.googleauthor | Leen Rigouts | - |
dc.contributor.googleauthor | Aditi Gupta | - |
dc.contributor.googleauthor | Jongseok Lee | - |
dc.contributor.googleauthor | Alaine Nyaruhirira Umubyeyi | - |
dc.contributor.googleauthor | Amy L. Davidow | - |
dc.contributor.googleauthor | Susan German | - |
dc.contributor.googleauthor | EunJin Cho | - |
dc.contributor.googleauthor | Ji-im Lee | - |
dc.contributor.googleauthor | Sang-Nae Cho | - |
dc.contributor.googleauthor | Cheon Tae Kim | - |
dc.contributor.googleauthor | David Alland | - |
dc.contributor.googleauthor | Hassan Safi | - |
dc.identifier.doi | 10.1128/AAC.03002-15 | - |
dc.contributor.localId | A03824 | - |
dc.relation.journalcode | J00189 | - |
dc.identifier.eissn | 1098-6596 | - |
dc.identifier.pmid | 27139478 | - |
dc.contributor.alternativeName | Cho, Sang Nae | - |
dc.contributor.affiliatedAuthor | Cho, Sang Nae | - |
dc.citation.volume | 60 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 4101 | - |
dc.citation.endPage | 4105 | - |
dc.identifier.bibliographicCitation | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Vol.60(7) : 4101-4105, 2016 | - |
dc.date.modified | 2017-10-24 | - |
dc.identifier.rimsid | 46848 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.